The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 77 (high attention) · dilution pressure high · listing risk low · governance risk elevated · runway 8.5 mo · strongest signal: Shelf filed (Aug 4, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language, going concern in 8-k, negative equity, runway 6–12 months) coexists with live selling machinery (atm program, shelf effective, shelf filed). Base case is a discounted raise; the question is when, not if.
A fresh shelf is on file with under a year of cash — the ingredients of an offering before the next 10-K. First shelf registration in 12 months filed with ~8.5 months of runway. Companies rarely file a shelf they do not intend to use.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 6, 2026 | ▼ Shelf effective | EFFECT notice 2026-08-06 filing | 21 |
| Aug 5, 2026 | ▼ Going-concern language | “going concern periodic” language in 10-Q (10-Q) filed 2026-08-05 filing | 33 |
| Aug 5, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (EX-99.1) filed 2026-08-05 filing | 31 |
| Aug 4, 2026 | ▼ Shelf filed | S-3 filed 2026-08-04 filing | 39 |
| Aug 4, 2026 | ▼ ATM program | “atm” language in S-3 (S-3) filed 2026-08-04 filing | 34 |
| Jul 24, 2026 | ▼ Holder rights modified | 8-K Item 3.03 filed 2026-07-24 (accepted 09:07 ET) filing | 30 |
| Jul 24, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-07-24 (accepted 09:07 ET) filing | 23 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-26,673,000 as of 2026-06-30 filing | 31 |
| Jun 30, 2026 | ▼ Runway 6–12 months | ~8.5 months runway: liquidity $40,484,000 as of 2026-06-30, burn $57,120,472/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 25 |
| Jun 30, 2026 | ▼ Cash < current liabilities | Liquidity $40,484,000 vs current liabilities $116,959,000 filing | 21 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →